The Effect of Rivaroxaban in Sickle Cell Disease

NCT02072668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia
Sickle Cell-Beta0-Thalassemia

Interventions

DRUG: rivaroxaban
DRUG: placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]